Commission Implementing Regulation (EU) 2023/116 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance oxamyl
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
268/2023
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2023/116 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance oxamyl
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2023/116 frá 16. janúar 2023 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilinu fyrir virka efnið oxamýl
Durchführungsverordnung (EU) 2023/116 der Kommission vom 16. Januar 2023 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für den Wirkstoff Oxamyl
Kommisjonens gjennomføringsforordning (EU) 2023/116 av 16. januar 2023 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for det aktive stoffet oksamyl
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.